• Mashup Score: 30
    Treatment-driven tumour heterogeneity and drug resistance: lessons from solid tumours - 2 year(s) ago

    Despite the advances that cancer therapies have made in recent years [1], primary or secondary treatment resistance to systemic therapies for advanced cancer stages is still a challenge to overcome [2]. While primary resistance is due to the presence of intrinsic mechanisms in tumour cells existing at the beginning of the treatment, secondary resistance occurs in tumours that are initially…

    Source: Cancer Treatment Reviews
    Categories: Latest Headlines, Oncologists2
    Tweet Tweets with this article
    • Profile photo of APassaroMD
      APassaroMD

      A great pleasure to share our last manuscript “Treatment-driven tumour #heterogeneity and drug #resistance: lessons from solid #tumours” ** Improving the understanding of #cancer heterogeneity is the key to improve the treatment performance Find it here https://t.co/rywfj5AgyF https://t.co/unKf8XmC3l

  • Mashup Score: 1
    Machine intelligence in non-invasive endocrine cancer diagnostics - Nature Reviews Endocrinology - 2 year(s) ago

    This Review explains core concepts in artificial intelligence (AI) and machine learning for endocrinologists. AI applications in endocrine cancer diagnostics are highlighted as well as research challenges and future directions for the field.

    Source: Nature
    Categories: Endocrinology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NatureRevEndo
      NatureRevEndo

      Nicole M. Thomasian, Ihab R. Kamel & Harrison X. Bai review the contributions of machine intelligence to the field of #endocrine imaging diagnostics for #tumours of the adrenal, pancreatic, pituitary and thyroid glands (£) https://t.co/1qmtrS1QC0 https://t.co/qWiFLiu3jZ

  • Mashup Score: 2
    Adrenal myelolipomas - 2 year(s) ago

    Adrenal myelolipomas are benign, lipomatous tumours with elements of myeloid cells, most of which present as adrenal incidentalomas and comprise 3·3–6·5% of all adrenal masses. Adrenal myelolipomas are usually unilateral (in 95% of cases), variable in size, most often found during midlife, and affect both sexes almost equally. On imaging, adrenal myelolipomas show pathognomonic imaging features…

    Source: The Lancet Diabetes & Endocrinology
    Categories: Endocrinology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of TheLancetEndo
      TheLancetEndo

      Adrenal myelolipomas https://t.co/eOjdpHFQj3 #lipomatous #tumours #adrenal #myelolipomas #incidentalomas https://t.co/QiFAFGqDqF

  • Mashup Score: 6
    Brain Metastasis from Solid Tumours | ESMO - 2 year(s) ago

    EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours

    Source: www.esmo.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of myESMO
      myESMO

      .@EANOassociation -ESMO Guidelines for the management of patients w/ #brainmetastasis from solid #tumours: covering clinical & pathological diagnosis, staging & risk assessment, treatment & follow-up. Treatment & management algorithms also provided. 🔎 https://t.co/r98wCLs1nD https://t.co/oPW3iJvoGV

  • Mashup Score: 0
    Adrenal myelolipomas - 3 year(s) ago

    Adrenal myelolipomas are benign, lipomatous tumours with elements of myeloid cells, most of which present as adrenal incidentalomas and comprise 3·3–6·5% of all adrenal masses. Adrenal myelolipomas are usually unilateral (in 95% of cases), variable in size, most often found during midlife, and affect both sexes almost equally. On imaging, adrenal myelolipomas show pathognomonic imaging features…

    Source: The Lancet Diabetes & Endocrinology
    Categories: Endocrinology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of TheLancetEndo
      TheLancetEndo

      Adrenal myelolipomas https://t.co/eOjdpHXraB #tumours #myeloid

  • Mashup Score: 28
    Adrenal myelolipomas - 3 year(s) ago

    Adrenal myelolipomas are benign, lipomatous tumours with elements of myeloid cells, most of which present as adrenal incidentalomas and comprise 3·3–6·5% of all adrenal masses. Adrenal myelolipomas are usually unilateral (in 95% of cases), variable in size, most often found during midlife, and affect both sexes almost equally. On imaging, adrenal myelolipomas show pathognomonic imaging features…

    Source: The Lancet Diabetes & Endocrinology
    Categories: Endocrinology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of TheLancetEndo
      TheLancetEndo

      #Adrenal #myelolipomas are benign, lipomatous #tumours with elements of myeloid cells, most of which present as adrenal #incidentalomas and comprise 3·3–6·5% of all adrenal masses. Read more here https://t.co/eOjdpHFQj3

Load More